IIC
BIVV

Integrated Investment Consultants’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Integrated Investment Consultants’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3K Hold
55
– – ﹤0.01% 593
2017
Q2 		$3K Buy
+55
New +$3.13K ﹤0.01% 562

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Integrated Investment Consultants's BIVV Position: Q3 2017 in Review

Integrated Investment Consultants held its Bioverativ Inc. Common Stock (BIVV) position steady in Q3 2017 at 55 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Integrated Investment Consultants first reported a position in BIVV in Q2 2017 and has held it in 2 quarters since. 446 funds tracked by Wall St. Rank hold BIVV as of Q3 2017.

  • Integrated Investment Consultants held 55 shares of Bioverativ Inc. Common Stock worth $3K as of Q3 2017.
  • Integrated Investment Consultants left its Bioverativ Inc. Common Stock share count unchanged in Q3 2017.
  • Bioverativ Inc. Common Stock made up ﹤0.01% of Integrated Investment Consultants's portfolio in Q3 2017, its #593 holding.
  • Integrated Investment Consultants first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and has held it in 2 quarters since.
  • 446 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q3 2017.

Based on Integrated Investment Consultants's 13F filing for Q3 2017, filed 26 Oct 2017.